SCHW
65
-2
DTE
38
-4
AIZ
78
2
AIG
47
6
VLO
42
2
BAX
27
-2
MMM
42
5
DVA
72
-3
BMY
61
-3
ABT
57
-5
SHW
70
2
XEL
65
-2
NRG
50
-2
OMC
64
-2
EMR
77
-2
EQT
57
-3
NI
73
3
LNC
45
-4
RRC
60
-3
KLAC
45
-4
SCHW
65
-2
DTE
38
-4
AIZ
78
2
AIG
47
6
VLO
42
2
BAX
27
-2
MMM
42
5
DVA
72
-3
BMY
61
-3
ABT
57
-5
SHW
70
2
XEL
65
-2
NRG
50
-2
OMC
64
-2
EMR
77
-2
EQT
57
-3
NI
73
3
LNC
45
-4
RRC
60
-3
KLAC
45
-4
Financhill
Back

Assembly Biosciences 10K Form

Sell
30

ASMB
Assembly Biosciences

Last Price:
16.79
Seasonality Move:
4.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ASMB News And Ratings

See the #1 stock for the next 7 days that we like better than ASMB

ASMB Financial Statistics

Sales & Book Value

Annual Sales: $7.16M
Cash Flow: $-17.12M
Price / Cash Flow: 3.58
Annual Sales: $5.47
Price / Book: 3.03

Profitability

EPS (TTM): -8.62000
Net Income (TTM): $-45.61M
Gross Margin: $0
Return on Equity: -111.22%
Return on Assets: -46.52%

Assembly Biosciences Earnings Forecast

Key Assembly Biosciences Financial Ratios

  • The Selling, General & Administrative Expenses for ASMB have been equal to 319.82% of Gross Profit Margin.
  • The Research & Development expenses have been 682.67% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 16 years have been positive in 11 years.

Assembly Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ASMB
CUSIP: 045396
Website: assemblybio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.74
Quick Ratio: 2.65

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ASMB Technical Analysis vs Fundamental Analysis

Sell
30
Assembly Biosciences (ASMB) is a Sell

Is Assembly Biosciences a Buy or a Sell?